Logo

American Heart Association

  122
  0


Final ID:

Pharmacogenomics - where does it help me?

  • Luzum, Jasmine  ( University of Michigan , Ann Arbor , Michigan , United States )
  • Wells, Quinn  ( VANDERBILT UNIVERSITY , Nashville , Tennessee , United States )
  • Pereira, Naveen  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Author Disclosures:
    Jasmine Luzum: DO have relevant financial relationships ; Consultant:Ariel Precision Medicine:Active (exists now) | Quinn Wells: DO NOT have relevant financial relationships | Naveen Pereira: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

What A Busy Cardiologist Needs to Know About Genetics

Friday, 11/07/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Should I get a polygenic risk score on my patient?

Bhattacharya Romit, Clarke Shoa, Kullo Iftikhar

Is it safe for my patient with genetic cardiomyopathy to exercise?

Lampert Rachel, Ackerman Michael, Saberi Sara, Day Sharlene

More abstracts from these authors:
Using tissues models to inform pharmacogenomics

Luzum Jasmine, Cavallari Larisa, Duarte Julio

What do I do with all these secondary findings?

Landstrom Andrew, Pereira Naveen, Ezekian Jordan

You have to be authorized to contact abstract author. Please, Login
Not Available